Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Go back to Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

WAVE Life Sciences (WVE) Misses Q4 EPS by 6c

March 22, 2023 7:37 AM EDT

WAVE Life Sciences (NASDAQ: WVE) reported Q4 EPS of ($0.47), $0.06 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $1.24 million versus the consensus estimate of $7.06 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

... More